Wockhardt Shares Zoom 14% On US FDA Approval For Breakthrough Antibiotic Zaynich

As reported by NDTV Profit - Latest

Wockhardt shares are rallying over 14% at Rs 2,330 apiece, as of 9:25 am.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on NDTV Profit - Latest ↗

Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.

INDIAN Q4 earnings review: Motilal Oswal highlights broad-based beat on estimates, lists 6 sectors that exceeded expectations Markets-Economic Times
INDIAN Global Markets: Japan's Nikkei tops 67,000 on AI boost; SoftBank becomes most valuable Japanese firm Markets-Economic Times
INDIAN Bitcoin begins June near $73,500 as ETF outflows cross $2 billion and geopolitical risks intensify Markets-Economic Times
INDIAN Global Markets: Australian shares end flat as banking losses overshadow miners' gains Markets-Economic Times
COMPANIES Explained: NSE extends F&O trading by 10 minutes. What changes for traders? Stocks-Markets-Economic Times
INDIAN Indian stock market: Nifty 50 hovers around key support of 23,500. What should investors do? mint - markets
INDIAN West Bengal cabinet expanded with 35 new ministers Markets
INDIAN Mukul Agrawal portfolio stock: Indo Count surges 14%, hits 52-week high Markets

Wockhardt Shares Zoom 14% On US FDA Approval For Breakthrough Antibiotic Zaynich

More from Market Samachar